MA36055B1 - Dérivés des pyridazin-3(2h)-ones, préparation , activités pharmacologiques et biologiques - Google Patents

Dérivés des pyridazin-3(2h)-ones, préparation , activités pharmacologiques et biologiques

Info

Publication number
MA36055B1
MA36055B1 MA36055A MA36055A MA36055B1 MA 36055 B1 MA36055 B1 MA 36055B1 MA 36055 A MA36055 A MA 36055A MA 36055 A MA36055 A MA 36055A MA 36055 B1 MA36055 B1 MA 36055B1
Authority
MA
Morocco
Prior art keywords
pharmacological
pyridazin
ones
biological activities
derivatives
Prior art date
Application number
MA36055A
Other languages
English (en)
Other versions
MA20150035A1 (fr
Inventor
M Hammed Ansar
Taoufik Jamal
Boukharssa Youness
Original Assignee
Univ Mohammed V Souissi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mohammed V Souissi filed Critical Univ Mohammed V Souissi
Priority to MA36055A priority Critical patent/MA36055B1/fr
Priority to PCT/MA2013/000039 priority patent/WO2014209094A1/fr
Publication of MA20150035A1 publication Critical patent/MA20150035A1/fr
Publication of MA36055B1 publication Critical patent/MA36055B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Les dérivés oxygénés de la pyridazine sont connus en thérapeutique pour la richesse de leurs potentiels pharmacologique : antihypertenseur et cardiotonique. Des propriétés antibactériennes, anti-inflammatoires et psychotropes sont également mentionnées dans la littérature. De ces considérations, résulte l'idée de synthétiser et d'étudier de nouvelles séries dérivées des pyridazin-3(2h}-ones et des pyridazin3( 2h)-thiones sur le plan toxicologique, et d'explorer leurs activités pharmacologiques et biologiques. Une étude récente a démontrée que des produits déjà synthétisés ne sont pas toxiques aux doses thérapeutiques et qu'ils sont doués d'effets sédatifs, myorelaxant et anxiolytique, ils ont montré aussi une activité antiinflammatoire, analgésique, antifongique et antimicrobienne.
MA36055A 2013-06-27 2013-06-27 Dérivés des pyridazin-3(2h)-ones, préparation , activités pharmacologiques et biologiques MA36055B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MA36055A MA36055B1 (fr) 2013-06-27 2013-06-27 Dérivés des pyridazin-3(2h)-ones, préparation , activités pharmacologiques et biologiques
PCT/MA2013/000039 WO2014209094A1 (fr) 2013-06-27 2013-12-05 Dérivés de pyridazin-3(2h)-one, préparation, activités pharmacologiques et biologiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA36055A MA36055B1 (fr) 2013-06-27 2013-06-27 Dérivés des pyridazin-3(2h)-ones, préparation , activités pharmacologiques et biologiques

Publications (2)

Publication Number Publication Date
MA20150035A1 MA20150035A1 (fr) 2015-02-27
MA36055B1 true MA36055B1 (fr) 2015-12-31

Family

ID=49883182

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36055A MA36055B1 (fr) 2013-06-27 2013-06-27 Dérivés des pyridazin-3(2h)-ones, préparation , activités pharmacologiques et biologiques

Country Status (2)

Country Link
MA (1) MA36055B1 (fr)
WO (1) WO2014209094A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210131357A (ko) * 2019-02-20 2021-11-02 지앙수 헨그루이 메디슨 컴퍼니 리미티드 6-옥소-1,6-디하이드로피리다진 프로드러그 유도체, 이의 제조 방법, 및 의약에서의 이의 응용
TW202220962A (zh) * 2020-08-19 2022-06-01 大陸商江蘇恒瑞醫藥股份有限公司 選擇性NaV抑制劑的結晶形式及其製備方法

Also Published As

Publication number Publication date
WO2014209094A1 (fr) 2014-12-31
MA20150035A1 (fr) 2015-02-27

Similar Documents

Publication Publication Date Title
MX2021007432A (es) Compuestos y composiciones para inhibir la actividad de shp2.
MA38391A1 (fr) Dérivés de pyridinyl et triazolone pyridinyl de fusion
MY176631A (en) Substituted tetrahydrocarbazole and carbazole carboxamide compounds useful as kinase inhibitors
MY192354A (en) 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors
MX2016004030A (es) Inhibidores sustituidos de nicotinamida de btk y su preparacion y uso en el tratamiento del cancer, inflamacion y enfermedad autoinmune.
MA38323A1 (fr) Dérivés pyrimidone et leur utilisation dans le traitement, l'amélioration ou la prévention d'une maladie virale
PH12016500531B1 (en) Compound inhibiting activities of btk and/or jak3 kinases
MA42239B1 (fr) Nouveaux dérivés d'hydroxyester, leur procédé de préparation et compositions pharmaceutiques les contenant
MD4539C1 (ro) 4-Fenilpiridine substituite pentru tratamentul bolilor asociate cu receptorul NK-1
MY161233A (en) Bis (fluoroalkyl)-1, 4-benzodiazepinone compounds
GT200900294A (es) Compuestos amino-heterocíclicos
DE602008004650D1 (de) Pyrimidinderivate als inhibitoren von phosphatidylinositol-3-kinase
EA201000365A1 (ru) Гетероциклические амиды, пригодные для лечения злокачественного новообразования и псориаза
NZ754764A (en) Pyrimidine tricyclic enone derivatives for inhibition of rorγ and other uses
MX2015016771A (es) Compuestos de carbazol carboxamida utiles como inhibidores de cinasa.
TN2016000188A1 (fr) Derives de purines 2,6-substitues et leur utilisation dans le traitement de troubles proliferatifs.
CR20220160A (es) Derivados de piridazin-3(2h)-ona fusionados con azol
MA44948A1 (fr) Inhibiteurs de bace 1
PH12021550443A1 (en) Pyridazinones and methods of use thereof
MA37691B1 (fr) 5-amino[1,4]thiazines comme inhibiteurs de bace1
MA37763A1 (fr) Difluoro-hexahydro-cyclopentaoxazinyles et difluoro-hexahydro-benzooxazinyles en tant qu'inhibiteurs de bace1
MA20150035A1 (fr) Dérivés des pyridazin-3(2h)-ones, préparation , activités pharmacologiques et biologiques
EA201491026A1 (ru) Производные 3-фенилизохинолин-1(2h)-она в качестве ингибиторов parp-1
MA39524A1 (fr) 1h-1,8-naphthyridin-2 ones utilisées comme composés anti prolifératifs
MA37927B2 (fr) Dérivés isoxazolidine